COVID-19 diagnostic approaches and modern mesenchymal stem cell-based treatment

R Kumar, S Kulshrestha, A Lathwal, PK Raghav - Stem Cells, 2024 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19) is a severe global pandemic known to be
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Rapid …

Mesenchymal stem cell research progress for the treatment of COVID-19

D Yao, H Ye, Z Huo, L Wu… - Journal of International …, 2020 - journals.sagepub.com
At the end of 2019, novel coronavirus (COVID-19) infection was detected in Wuhan City,
Hubei Province, China. The COVID-19 infection characteristics include a long incubation …

Taming of Covid-19: potential and emerging application of mesenchymal stem cells

N Najafi-Ghalehlou, MH Roudkenar, HZ Langerodi… - Cytotechnology, 2021 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) has turned out to cause a pandemic, with a sky …

Mesenchymal stem cells for the treatment of COVID-19: why and when they should be used?

H Darici, E Sun, DK Irmak, E Karaöz - Journal of Stem Cells, 2020 - search.ebscohost.com
COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2), which caused deaths of more than 300.000 people around the world within …

[PDF][PDF] Mesenchymal Stem Cells for the Treatment of Patients with COVID-19 Severe/Critical Category: A Review

AD Pramanti, MI Barliana… - The Open Public …, 2024 - openpublichealthjournal.com
COVID-19 has developed into a public health emergency of international concern and is a
major threat to global health. Several studies have been conducted with the aim of …

Mesenchymal stem cells as a treatment strategy for coronavirus disease 2019 (COVID-19): need for authority regulations and clinical guidelines

AC Tufan - Current stem cell research & therapy, 2021 - ingentaconnect.com
The cause of Coronavirus Disease 2019 (COVID-19) known as the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly designated 2019-nCoV) was …

Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

Mesenchymal stem cells in COVID-19: a journey from bench to bedside

KK Sahu, AD Siddiqui, J Cerny - Laboratory medicine, 2021 - academic.oup.com
The COVID-19 pandemic has led to a major setback in both the health and economic
sectors across the globe. The scale of the problem is enormous because we still do not have …

[HTML][HTML] Mesenchymal stem cells in the treatment of new coronavirus pandemic: a novel promising therapeutic approach

S Razi, Z Molavi, SA Mirmotalebisohi… - Advanced …, 2022 - ncbi.nlm.nih.gov
After severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome
(MERS) outbreaks, coronavirus disease 2019 (COVID-19) is the third coronavirus epidemic …

[HTML][HTML] Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19

M Jeyaraman, A John, S Koshy, R Ranjan… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …